Invariant NKT cell product
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Invariant NKT cell product, covering 2018-07-30 to 2018-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Expansion of Invariant NKT Cells for a Cell Immunotherapeutic Approach Allowing the Control of Graft Versus Host-disease and Preserving the Graft Versus Leukemia Effect After Allogeneic Hematopoietic Stem Cell Transplantation